An official website of the United States government
Home
Name
TAXOL/CBDCA
Alternate names
CBDCA
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for TAXOL/CBDCA
Name
Alternate Names
Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin
Abbreviations
LCR
VCR
VNCR
Category
Chemotherapy
Subcategory
Plant alkyloid--antimetabolite
NSC Number
067574
67574
Primary Site
None
Histology
None
Remarks
Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.
Coding
This drug should be coded
Name
Alternate Names
BMS-181339-01
BMY-45622
Taxol
Abbreviations
None
Category
Chemotherapy
Subcategory
Mitotic inhibitor
plant alkaloid
Taxane
NSC Number
125973
673089
Primary Site
Histology
None
Remarks
Phase I (gastric) FDA approved uses on breast, ovarian, non-small cell lung cancers, and Kaposi's sarcoma. Bristol-Myers Squibb.
Coding
This drug should be coded
Name
Alternate Names
JM 8
JM-8
JM8
Paraplatin
Abbreviations
CBDCA
Category
Chemotherapy
Subcategory
Alkylating agent
Platinum analog
NSC Number
241240
Primary Site
All cancers
Histology
None
Remarks
A platinum-salt alkylating agent.
Coding
This drug should be coded
